WNT2-Mediated FZD2 Stabilization Regulates Esophageal Cancer Metastasis via STAT3 Signaling
Yufei Fu,Qi Zheng,Yingying Mao,Xiyi Jiang,Xin Chen,Pei Liu,Bin Lv,Tuxiong Huang,Jiao Yang,Yongran Cheng,Xiaoyi Dai,Chunyan Dai,Xi Wang,Yifei Yin,Tengjiao Song,Weiyang Jin,Chang Zou,Tianhui Chen,Li Fu,Zhe Chen
DOI: https://doi.org/10.3389/fonc.2020.01168
IF: 4.7
2020-07-16
Frontiers in Oncology
Abstract:Esophageal cancer micro environment factor WNT2 was critical in cancer metastasis. However, very little is known about WNT2 receptors and their role in the malignant progression of ESCC. The clinical significance and underlying molecular mechanisms of FZD2, one of the receptors of WNT2, was further investigated in ESCC. We found that FZD2 expression was positively correlated with WNT2 levels in clinical ESCC specimens through database analysis. Upregulated FZD2 expression was detected in 69% (69/100) of the primary ESCC cases examined, and increased FZD2 expression was significantly correlated with poor prognosis (<i>P</i> < 0.05). Mechanistically, FZD2 induced the migration and invasion of ESCC cells by regulating the FZD2/STAT3 signaling. <i>In vivo</i> xenograft experiments further revealed the metastasis-promoting role of FZD2 in ESCC. Moreover, we found that the WNT2 ligand could stabilize and phosphorylate the FZD2 receptor by attenuating FZD2 ubiquitination, leading to the activation of STAT3 signaling and the initiation of ESCC cell metastasis. Collectively, our data revealed that a novel non-canonical WNT2/FZD2/STAT3 signaling axis is critical for ESCC progression. Strategies targeting this specific signaling axis might be developed to treat patients with ESCC.
oncology